ReviewCancer medicine2026
Mechanistic Insights and Therapeutic Potential of Small Nucleolar RNA Host Genes in the Carcinogenesis of Hepatocellular Carcinoma.
Review in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundHepatocellular carcinoma (HCC) is one of the major factors endangering human health due to its poor prognosis, resulting from difficulties in early diagnosis and lack of effective treatment measures. Long non-coding RNAs (lncRNAs), which are RNA molecules that do not translate into proteins, play essential roles in various tumor malignancy mechanisms. Among these, small nucleolar host genes (SNHGs) represent a specific subgroup of lncRNAs that have recently been shown to be critically involved in the development of HCC.
objectiveThis review aims to summarize recent findings regarding the role of SNHGs in HCC carcinogenesis, and to clarify their mechanistic functions in cancer progression as well as their potential as diagnostic markers and therapeutic targets.
methodsA comprehensive literature search was performed in the PubMed database using the following keywords: "small nucleolar host gene", and "hepatocellular carcinoma", or "liver cancer". Relevant literature was retrieved and screened to synthesize the latest research findings on the roles of SNHGs in HCC carcinogenesis. No restrictions were predefined on the publication time of the included literature, and studies focusing on the mechanistic insights and therapeutic potential of SNHGs in HCC were prioritized for inclusion in this narrative review.
resultsAbnormal expression of SNHGs in HCC affects many facets of the disease, including tumor cell proliferation, stemness, invasion, migration, apoptosis, autophagy, ferroptosis (an iron-dependent form of cell death), and pyroptosis (a highly inflammatory form of programmed cell death), as well as metabolic processes such as glycolysis, lipid and cholesterol metabolism. Furthermore, these expressions can alter the tumor microenvironment and contribute to resistance against sorafenib, a common treatment for HCC. Numerous studies have further revealed SNHGs promote the onset and progression of HCC through competing endogenous RNA (ceRNA, different RNA molecules compete for same microRNAs) network. Additionally, recent research shows that non-ceRNA mechanisms, including small nucleolar RNA (snoRNA) mediated regulation, epigenetic regulation, and modulation of mRNA stability, also contribute to SNHGs' regulation of HCC development and progression.
conclusionSNHGs play critical regulatory roles in HCC carcinogenesis and progression through both ceRNA and non-ceRNA mechanisms. They hold potential as promising diagnostic markers and therapeutic targets for HCC, providing new insights for the clinical management of this disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.